Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
出版年份 2021 全文链接
标题
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-09
DOI
10.1186/s13046-020-01820-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Targeting hypoxia in tumor: a new promising therapeutic strategy
- (2020) Maria Carla Bosco et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
- (2020) Pearl Lee et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Combining microenvironment normalization strategies to improve cancer immunotherapy
- (2020) Fotios Mpekris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
- (2020) Raefa Abou Khouzam et al. SEMINARS IN CANCER BIOLOGY
- Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
- (2020) Yolla Haibe et al. Frontiers in Oncology
- The yin and yang functions of extracellular ATP and adenosine in tumor immunity
- (2020) Li-li Feng et al. Cancer Cell International
- The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome
- (2020) Wai Hoong Chang et al. CANCER LETTERS
- The CD47-SIRPα Immune Checkpoint
- (2020) Meike E.W. Logtenberg et al. IMMUNITY
- Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
- (2020) Aohan Hou et al. Frontiers in Immunology
- Hypoxia-Driven Immune Escape in the Tumor Microenvironment
- (2020) Alyssa Vito et al. Cells
- Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia
- (2020) Cao Dai Phung et al. JOURNAL OF CONTROLLED RELEASE
- Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein
- (2020) Nicolas Torres et al. Journal for ImmunoTherapy of Cancer
- Resolution of spatial and temporal heterogeneity in bevacizumab-treated breast tumors by eigenspectra multispectral optoacoustic tomography
- (2020) Evangelos Liapis et al. CANCER RESEARCH
- Shaping of Dendritic Cell Function by the Metabolic Micro-Environment
- (2020) Eline Constance Brombacher et al. Frontiers in Endocrinology
- Lenvatinib (len) plus pembrolizumab (pembro) for the first-line treatment of patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 3 LEAP-002 study.
- (2019) Josep M Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting hypoxia-induced carbonic anhydrase IX enhances immune checkpoint blockade locally and systemically
- (2019) Shawn C Chafe et al. Cancer Immunology Research
- Macrophages and Metabolism in the Tumor Microenvironment
- (2019) Ilio Vitale et al. Cell Metabolism
- Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients
- (2019) Michael J. Duffy et al. CLINICAL CHEMISTRY
- Light triggered oxygen-affording engines for repeated hypoxia-resistant photodynamic therapy
- (2019) Tian-Jiao Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Vascular regulation of antitumor immunity
- (2019) Lance L. Munn et al. SCIENCE
- Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
- (2019) Muhammad Zaeem Noman et al. Cells
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Metabolic regulation of gene expression by histone lactylation
- (2019) Di Zhang et al. NATURE
- Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
- (2019) Jie Feng et al. Cancers
- Hypoxia and acidosis: immune suppressors and therapeutic targets
- (2018) Sultan Damgaci et al. IMMUNOLOGY
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation
- (2018) Qiong Wu et al. Cell Death & Disease
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity
- (2018) Stéphane Terry et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α–mediated tumor progression
- (2018) Na Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter
- (2017) Meriem Hasmim et al. JOURNAL OF IMMUNOLOGY
- Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective
- (2017) Deepak Bhattarai et al. MEDICINAL RESEARCH REVIEWS
- Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
- (2017) Si-Rui Ma et al. Molecular Cancer
- Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
- (2017) Guan-Zhong Qiu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
- (2017) David Kung-Chun Chiu et al. Nature Communications
- Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
- (2017) Ewelina Krzywinska et al. Nature Communications
- Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells
- (2017) Marica Garziera et al. Journal of Immunology Research
- Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine
- (2017) Peter Vaupel et al. Frontiers in Immunology
- Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
- (2017) David J. Pinato et al. OncoImmunology
- Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells
- (2017) Iman Azimi et al. Scientific Reports
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
- (2016) Yoshihiro Komohara et al. ADVANCED DRUG DELIVERY REVIEWS
- Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
- (2016) Francis W Hunter et al. BRITISH JOURNAL OF CANCER
- Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer
- (2016) Nasim Kheshtchin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Abstract 3209: CRLX101, an investigational nanoparticle-drug conjugate of camptothecin, demonstrates synergy with immunotherapy agents in preclinical models
- (2016) Douglas Lazarus et al. CANCER RESEARCH
- Decrease in circulating plasmacytoid dendritic cells during short-term systemic normobaric hypoxia
- (2016) Atilla Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8+ T-cell recognition of stressed cells
- (2016) Takanori Sasaki et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel–Lindau Gene Mutation Status
- (2016) Yosra Messai et al. EUROPEAN UROLOGY
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
- (2016) Vinit Kumar et al. IMMUNITY
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2
- (2016) Layale Yaghi et al. Oncotarget
- Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer
- (2016) Li Ren et al. Oncotarget
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Hypoxia and antitumor CD8+ T cells: An incompatible alliance?
- (2016) Romain Vuillefroy de Silly et al. OncoImmunology
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing
- (2015) Yosra Messai et al. Autophagy
- Something in the Air: Hyperoxic Conditioning of the Tumor Microenvironment for Enhanced Immunotherapy
- (2015) Robert D. Leone et al. CANCER CELL
- Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210
- (2015) Muhammad Zaeem Noman et al. CANCER RESEARCH
- Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway
- (2015) Valéry L. Payen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity
- (2015) Jee H. Lee et al. IMMUNITY
- Hypoxia-Inducible Factor-2 Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury
- (2015) J. Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo
- (2015) De-Kuan Chang et al. Molecular Cancer
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
- (2015) Huimin Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Immune Response Regulation in the Tumor Microenvironment by Hypoxia
- (2015) Sara Labiano et al. SEMINARS IN ONCOLOGY
- ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
- (2014) Y. Messai et al. CANCER RESEARCH
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Autophagic degradation of GZMB/granzyme B
- (2013) Elodie Viry et al. Autophagy
- Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells
- (2013) Haitao Zhu et al. Cancer Cell International
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
- (2013) G. Curigliano et al. CLINICAL CANCER RESEARCH
- Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
- (2013) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cutting Edge: Hypoxia-Induced Nanog Favors the Intratumoral Infiltration of Regulatory T Cells and Macrophages via Direct Regulation of TGF- 1
- (2013) M. Hasmim et al. JOURNAL OF IMMUNOLOGY
- Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
- (2013) Andrew L Doedens et al. NATURE IMMUNOLOGY
- EO9 (Apaziquone): from the clinic to the laboratory and back again
- (2012) Roger M Phillips et al. BRITISH JOURNAL OF PHARMACOLOGY
- Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration
- (2012) Theresa Köhler et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The hypoxic environment reprograms the cytokine/chemokine expression profile of human mature dendritic cells
- (2012) Fabiola Blengio et al. IMMUNOBIOLOGY
- Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
- (2012) K. Hendricksen et al. JOURNAL OF UROLOGY
- Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
- (2012) E. T. Clambey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
- (2012) S. J. Conley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
- (2012) Asís Palazón et al. Cancer Discovery
- Blocking Hypoxia-Induced Autophagy in Tumors Restores Cytotoxic T-Cell Activity and Promotes Regression
- (2011) M. Z. Noman et al. CANCER RESEARCH
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
- (2011) Eric V. Dang et al. CELL
- Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma
- (2011) P. Correale et al. CLINICAL CANCER RESEARCH
- Hypoxia-Dependent Inhibition of Tumor Cell Susceptibility to CTL-Mediated Lysis Involves NANOG Induction in Target Cells
- (2011) Meriem Hasmim et al. JOURNAL OF IMMUNOLOGY
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo
- (2010) M. C. Bosco et al. BLOOD
- The Cooperative Induction of Hypoxia-Inducible Factor-1 and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis
- (2009) M. Z. Noman et al. JOURNAL OF IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started